Wms Partners, LLC Abbott Laboratories Transaction History

Wms Partners, LLC

$1.7 Billion
Q3 2024

A detailed history of Wms Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wms Partners, LLC holds 56,587 shares of ABT stock, worth $6.47 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

56,587

Previous 56,176 0.73%

Holding current value

$6.47 Million

Previous $5.84 Million 10.52%

% of portfolio

0.38%

Previous 0.39%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $41,128 - $48,551	411 Added 0.73%	56,587 $6.45 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $54,192 - $60,492	-538 Reduced 0.95%	56,176 $5.84 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $537,743 - $593,913	-4,910 Reduced 7.97%	56,714 $6.45 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $168,023 - $205,675	-1,863 Reduced 2.93%	61,624 $6.78 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $247,613 - $297,095	-2,592 Reduced 3.92%	63,487 $6.15 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $240,864 - $268,373	-2,390 Reduced 3.49%	66,079 $7.2 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $232,754 - $273,966	-2,403 Reduced 3.39%	68,469 $6.93 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $417,503 - $489,795	-4,392 Reduced 5.84%	70,872 $7.78 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $486,412 - $563,174	-5,027 Reduced 6.26%	75,264 $7.28 Million
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $140,754 - $170,127	-1,379 Reduced 1.69%	80,291 $8.72 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $131,465 - $160,313	1,153 Added 1.43%	81,670 $9.67 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $201,368 - $246,564	-1,743 Reduced 2.12%	80,517 $11.3 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $94,494 - $104,538	-810 Reduced 0.98%	82,260 $9.72 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $109,810 - $129,262	-1,038 Reduced 1.23%	83,070 $9.63 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $333,812 - $393,281	-3,067 Reduced 3.52%	84,108 $10.1 Million
Q4 2020 Feb 17, 2021	BUY	$105.0 - $114.42 $29,820 - $32,495	284 Added 0.33%	87,175 $9.55 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $188,686 - $229,146	-2,059 Reduced 2.31%	86,891 $9.46 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $1.1 Million - $1.41 Million	14,350 Added 19.24%	88,950 $8.13 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $215,786 - $315,539	-3,435 Reduced 4.4%	74,600 $5.89 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $62,650 - $69,745	-798 Reduced 1.01%	78,035 $6.78 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $89,205 - $96,726	-1,090 Reduced 1.36%	78,833 $6.6 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $333,498 - $388,960	-4,576 Reduced 5.42%	79,923 $6.72 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $129,791 - $156,917	-1,960 Reduced 2.27%	84,499 $6.76 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $222,904 - $252,518	-3,400 Reduced 3.78%	86,459 $6.25 Million
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $23,107 - $27,876	-380 Reduced 0.42%	89,859 $6.59 Million
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $70,465 - $77,772	1,224 Added 1.38%	90,239 $5.5 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $330,642 - $373,831	-5,876 Reduced 6.19%	89,015 $5.33 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $78,480 - $84,021	-1,462 Reduced 1.52%	94,891 $5.42 Million
Q3 2017 Oct 27, 2017	SELL	$48.06 - $53.64 $129,521 - $144,559	-2,695 Reduced 2.72%	96,353 $5.14 Million
Q2 2017 Aug 09, 2017	BUY	N/A	99,048	99,048 $4.82 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.

Account